vision funding
51 open opportunities tagged vision, across federal agencies and private foundations. Sorted by deadline.
NIH Director’s Early Independence Award (DP5 Clinical Trial Optional)
The NIH Director's Early Independence Award helps exceptional new scientists start independent research careers right after finishing their doctoral degree or clinical training, forgoing postdoctoral training.
7 review criteria on fileDoW Vision, Mentored Clinical Research Award
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Mentored Clinical Research Award (MCRA) supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training.
Review criteria on fileDoW Neurofibromatosis Research Academy – Leadership Award
Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Neurofibromatosis Research Academy – Leadership Award (NFRALA) supports visionary, established neurofibromatosis (NF) investigators with documented history of neurofibromatosis funding, publications, strong mentorship and commitment to leadership to serve as…
Review criteria on fileNCI Community Oncology Research Program (NCORP) Research Bases (UG1 Clinical Trial Required)
This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human research study results through accrual in a variety of community settings.
7 review criteria on fileAvant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
The National Institute on Drug Abuse (NIDA) Avant-Garde and Avenir Awards Program for HIV Research supports exceptionally creative scientists, who propose high-impact studies that open new areas of HIV research in the context of substance use and Substance Use Disorders (SUD) and/or lead to new avenues for HIV prevention, treatment and…
7 review criteria on fileLimited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
S.S.
13 review criteria on fileCancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Purpose This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. NCI-Designated Cancer Centers serve as major sources of discovery into the nature of cancer and of the development of more effective approaches to prevention, diagnosis, and therapy.
11 review criteria on fileLogistics Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U24 Clinical Trials Not Allowed)
Purpose The Logistics Center will provide the administrative infrastructure necessary to facilitate and coordinate PRIMED-AI activities to maximize the impact of the PRIMED-AI Program. Within the Logistics Center , three integrated Cores will serve the functions of Administration, Evaluation, and Outreach.
7 review criteria on fileSingle-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
NOFO Research Objectives This NOFO supports applications to develop and conduct investigator-initiated single-site clinical trials. Clinical trials supported by this NOFO include Phase II and above clinical trials.
3 review criteria on fileData Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
NOFO Research Objectives This NOFO supports applications to develop and conduct a Data Coordinating Center (DCC) for investigator-initiated multi-site clinical trials submitted to the collaborating Clinical Coordinating Center NOFO ( PAR-27-012 ).
8 review criteria on fileClinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
NOFO Research Objectives This NOFO supports applications to develop and conduct a Clinical Coordinating Center (CCC) for investigator-initiated multi-site clinical trials. Clinical trials supported by this NOFO include Phase II and above clinical trials that will enroll participants from two or more recruitment sites.
3 review criteria on fileValidation Center for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U54 Clinical Trials Not Allowed)
Purpose The Validation Center (VC) will serve as a dedicated hub for the comprehensive evaluation and characterization of AI-enabled , image-based, multimodal Clinical Decision Support (CDS) tools developed by the PRIMED-AI Consortium, to ensure these tools are reliable, reproducible and generalizable.
9 review criteria on fileDiscovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowed)
Technological innovations in chemical synthesis, cheminformatics, structural biology, and high throughput bioactivity and drug property assays have allowed rapid discovery of novel, small-molecule probes for the study of disease-related biological processes and mechanisms in academic environments.
3 review criteria on fileResearch Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Purpose Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship.
3 review criteria on fileBioengineering Research Grants (BRG) (R01 Clinical Trial Optional)
Purpose The goal for a bioengineering research grant (BRG) is to foster the development of an innovative technology, model, technique, design, or method that has the potential for a significant impact on biomedical research by infusing principles and concepts from the quantitative sciences.
3 review criteria on fileBRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
Background Since 2014, the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative has aimed to accelerate the development and application of innovative neurotechnologies, enabling researchers to produce a new dynamic picture of the brain that reveals how individual cells and complex neural circuits interact in…
7 review criteria on fileHEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Background: HEAL Initiative The NIH Helping to End Addiction Long-term (HEAL) Initiative: This notice of funding opportunity (NOFO) encourages applications in support of the NIH's HEAL initiative to speed scientific solutions to the national opioid public health crisis.
3 review criteria on fileDevelopment and Testing of a Multi-use Frameworks Playbook for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (U01 Clinical Trial Not Allowed)
Purpose To promote the success of clinically relevant, multimodal AI tools in real-world environments, the PRIMED-AI Program will develop of standardized processes to organize and support the emerging multimodal-AI field.
3 review criteria on fileNEI Clinical Research Study Planning Grant Program (R34 Clinical Trial Not Allowed)
The NEI supports large-scale clinical vision research projects, including randomized clinical trials and epidemiologic studies on eye/vision conditions.
3 review criteria on fileNEI Research Grant for Vision-Related Secondary Data Analysis (R21 Clinical Trial Not Allowed)
, electronic health records). This NOFO may be used to develop new statistical methodologies or test hypotheses using existing data, but this NOFO must not be used to support the collection of new data.
3 review criteria on filePRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Purpose Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) NOFOs seek to spur on the development of innovative, reliable, cost-effective, and sustainable multimodal AI-based clinical decision support (CDS) tools with the potential for transformational impact.
3 review criteria on fileModel-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
Purpose The Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) NOFOs seek to spur on the development of innovative, reliable, cost-effective, and sustainable multimodal AI-based clinical decision support (CDS) tools with the potential for transformational impact.
3 review criteria on fileNSF's Eddie Bernice Johnson Inclusion across the Nation of Communities of Learners of Underrepresented Discoverers in Engineering and Science (INCLUDES) Initiative
jsp ). The Big Ideas represent unique opportunities to position our Nation at the cutting edge of global science and engineering leadership by bringing together diverse disciplinary perspectives to support convergence research.
2 review criteria on file · agency frameworkDoW Bone Marrow Failure, Idea Development Award
Summary: The BMFRP Idea Development Award (IDA) is intended to support innovative ideas and high-impact approaches based on scientifically sound evidence to move toward the BMFRP’s vision of understanding and curing BMF diseases.
Review criteria on fileDoW Vision, Translational Research Award
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance.
Review criteria on fileDoW Vision, Investigator-Initiated Research Award
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Investigator-Initiated Research Award (IIRA) supports basic through early translational research that will yield highly impactful discoveries or major advancements in the research and/or patient care of eye injury and/or visual dysfunction related to military exposure .
Review criteria on fileDoW Vision, Clinical Trial Award
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction.
Review criteria on fileCenters of Research Excellence in Science and Technology
CREST Center awards provide support to enhance the research capabilities of Minority-serving institutions (MSIs) through the establishment of centers that effectively integrate education and research.
2 review criteria on file · agency frameworkFiscal Year (FY) 2027 Department of the Navy (DoN) Historically Black Colleges and Universities/Minority Institutions (HBCU/MI) Program
S.S.
Review criteria on fileDevelopment of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
The NIH Office of Research Infrastructure Programs (ORIP) administers two extramural construction programs: the Biomedical Research Facilities (BRF) program and the HIV/AIDS Research Facilities (HRF) program.
5 review criteria on fileEPSCoR Research Infrastructure Improvement Program: Focused EPSCoR Collaborations Program (FEC)
The Established Program to Stimulate Competitive Research (EPSCoR) is designed to fulfill the mandate of the National Science Foundation (NSF) to promote scientific progress nationwide. EPSCoR eligibility status is yearly updated and reported in the EPSCoR website (see EPSCoR eligibility).
2 review criteria on file · agency frameworkDiabetes Research Centers (P30 Clinical Trial Optional)
Background According to the CDC, the prevalence of diabetes mellitus in the United States continues to rise over time.6% of the US Population) and about twice that prevalence in those over 65.
9 review criteria on fileBRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
The BRAIN Initiative Since 2014, the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative has aimed to accelerate the development and application of innovative neurotechnologies, enabling researchers to produce a new dynamic picture of the brain that reveals how individual cells and complex neural circuits…
3 review criteria on fileBRAIN Initiative: Exploratory Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (R61 Clinical Trial Not Allowed)
Background Since 2014, the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative has aimed to accelerate the development and application of innovative neurotechnologies, enabling researchers to produce a new dynamic picture of the brain that reveals how individual cells and complex neural circuits interact in…
3 review criteria on fileExpeditions in Computing
The far-reaching impact and rate of innovation in the computer and information science and engineering fields has been remarkable, generating economic prosperity and enhancing the quality of life for people throughout the world.
2 review criteria on file · agency frameworkNSF National Quantum Virtual Laboratory - Quantum Testbeds
) in quantum information science and technology. In conformance with the NQI goals, an argument 2-5 was set forth for a renewed emphasis on identifying and fostering early adoption of quantum technologies to transform the field of Quantum Information Science and Engineering (QISE) and to accelerate broader impacts on society.
2 review criteria on file · agency frameworkBrightFocus Foundation — Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma. Search Translation EN ES FR DE ID About the Disease What is Glaucoma?
BrightFocus Foundation — The Immune Landscape of the Human Optic Nerve Head
The Immune Landscape of the Human Optic Nerve Head BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma. Search Translation EN ES FR DE ID About the Disease What is Glaucoma?
BrightFocus Foundation — Spatial Responses to Elevated Pressure in the Human Optic Nerve Head
Spatial Responses to Elevated Pressure in the Human Optic Nerve Head BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma. Search Translation EN ES FR DE ID About the Disease What is Glaucoma?
BrightFocus Foundation — Activating the Eye’s Own Nitric Oxide to Fight Glaucoma
Activating the Eye’s Own Nitric Oxide to Fight Glaucoma BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma. Search Translation EN ES FR DE ID About the Disease What is Glaucoma?
Robert Wood Johnson Foundation — Grantee Stories
Stories of RWJF Grantee Impact | RWJF | RWJF Skip to main content Grantee Stories Professor of Alaska Native Languages at the University of Alaska Southeast, X̱’unei Lance Twitchell, at the Haa Tóoch Lichéesh Coalition offices in downtown Juneau, Alaska.
Climate Program Office for FY 2012
Changing climate confronts society with significant economic, health, safety, and national security challenges. NOAA advances scientific and technical programs to help society cope with, and adapt to, today's variations in climate and to prepare for tomorrow's.
Review criteria on fileParticulate and Multiphase Processes
TheParticulate and Multiphase Processesprogram is part of the Transport Phenomena cluster, which also includes 1) theCombustion and Fire Systemsprogram; 2) theFluid Dynamicsprogram; and 3) theThermal Transport Processesprogram.
2 review criteria on file · agency frameworkInterfacial Engineering
The Interfacial Engineering program is part of the Chemical Process Systems cluster, which also includes: 1) the Catalysis program; 2) the Electrochemical Systems program; and 3) the Process Systems, Reaction Engineering, and Molecular Thermodynamics program.
2 review criteria on file · agency frameworkTactical Behaviors for Autonomous Maneuver
**UPDATE 5 APRIL 2024: The proposal submission date has been updated to 24 April 2024. The FOA has been amended to reflect this submission date and include a Question and Answer document based on questions received from interested applicants.
NASA Innovative Advanced Concepts (NIAC) Phase II
The National Aeronautics and Space Administration (NASA) Headquarters anticipates release of a solicitation, titled “NASA Innovative Advanced Concepts (NIAC), Phase II,” as an Appendix to the Space Technology Mission Directorate (STMD) NASA Research Announcement (NRA), titled “Space Technology Research, Development, Demonstration, and…
3 review criteria on file · agency frameworkTransport Phenomena (TP)
The Transport Phenomena (TP) program supports fundamental research to understand, model, and control the transport of mass, momentum, energy, and species across multiple scales.
2 review criteria on file · agency frameworkMultilateral Partnerships Leveraging Excellence
Many of the most pressing challenges in research and innovation require collaboration across national and disciplinary boundaries to achieve important advances.
2 review criteria on file · agency frameworkGrowing Research Access for Nationally Transformative Economic Development
S. organizations.
2 review criteria on file · agency frameworkBrightFocus Foundation — Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease
Hidden RNA Alterations by Jumping Genes in Alzheimer's Disease BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma.
BrightFocus Foundation — Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease
Artificial Intelligence-Guided Drug Discovery for Alzheimer's Disease BrightFocus Foundation BrightFocus is a premier funder of groundbreaking research in an urgent effort to discover cures for Alzheimer’s disease, macular degeneration, and glaucoma.
See which vision opportunities fit your work
An account is free and shows the full announcement, the review criteria reviewers score you against, and whether you are actually eligible — including the windows that close before the deadline does.
No card required.